PDS Biotechnology (PDSB) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts PDSB Hot Sheet
Join SI Premium – FREE
PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- PDS Biotech shifts focus to PDS0301 in colorectal cancer
- Stardust Power (SDST) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
